GHK-Cu: collagen, formulation, hair
Collagen production can change without the cell count changing. I like that precise result better than a sweeping claim about rejuvenation.
More collagen from the cells already there
In the 1988 experiment with cultured human fibroblasts, GHK-Cu stimulated collagen synthesis independently of any change in cell number. Fibroblasts are cells that help make the supporting material around them, including collagen. The experiment located the response in what the cells produced.
I like the distinction between making more material and making more cells. It gives the claim a physical job. A culture dish still supplies a very limited setting for that job; skin has barriers, other cell types and a whole body around it.
The tissue-remodelling review describes a much broader set of proposed repair actions across experimental models. The breadth is interesting, though each proposed action needs evidence at the scale where a benefit is claimed.
Topical formulation
GHK is the short peptide; GHK-Cu has copper bound to it. Copper tripeptide-1 and prezatide copper are names for the copper form. The skin-regeneration review describes why copper coordination matters to the repair research. Studies using free GHK need to retain that identity when their findings are discussed.
Delivery then changes the question again. The 2025 topical review treats poor passage through the outer skin layer as a central problem. A cream’s other ingredients influence the amount reaching tissue, which makes formulation a substantive part of a topical result.
In the excised-human-skin penetration experiment, researchers measured copper crossing skin over 48 hours and copper retained within it. The measurement followed copper. It cannot establish that the intact peptide-copper complex travelled unchanged through living skin. I trust the copper measurement more when its description stays this narrow. The broad phrase “absorbed through skin” conceals the distinction.
Skin percentages and a combined hair treatment
The topical review reports increased procollagen synthesis in 70% of GHK-Cu-treated subjects, compared with 50% for vitamin C and 40% for retinoic acid. Procollagen is a precursor used to make collagen. Those percentages count people showing a measured increase; they do not describe the size of a wrinkle reduction.
An earlier skin review repeats the 70%, 50% and 40% comparison. Repeated summaries of a finding provide no extra trial participants. That inflation of human evidence troubles me.
The six-month hair trial in 45 men tested a complex of GHK peptide and 5-aminolevulinic acid. Hair counts increased more than with placebo, and no adverse events were reported in the study. The result concerns that combination. It leaves the separate contribution of GHK-Cu unresolved.
Gene expression
The 2018 gene-data review describes expression changes in cell and database work. Gene expression measures the activity of cellular instructions. It requires a further chain of evidence to connect such a change to a person’s skin, wound healing or ageing. I resist compressing that chain into “anti-ageing.”
People using topical copper peptides report firmness, hydration, smoother texture and thicker-looking hair, as well as redness, itching, dryness, breakouts and pigment changes. These are anecdotal impressions, not clinical evidence. Reports about injections have the same verification problem and concern an unapproved route.
GHK-Cu has no approved drug indication. Systemic use lacks validated human safety and pharmacokinetic evidence. Possible copper accumulation is a theoretical concern, especially where copper handling is impaired. Acids and other formulation conditions can also disrupt the copper complex. A pleasing reflection cannot settle those questions; the small topical studies remain the appropriate human frame.